97 related articles for article (PubMed ID: 21548553)
21. S-Adenosylhomocysteine increases beta-amyloid formation in BV-2 microglial cells by increased expressions of beta-amyloid precursor protein and presenilin 1 and by hypomethylation of these gene promoters.
Lin HC; Hsieh HM; Chen YH; Hu ML
Neurotoxicology; 2009 Jul; 30(4):622-7. PubMed ID: 19635394
[TBL] [Abstract][Full Text] [Related]
22. Melatonin prevents amyloid protofibrillar induced oxidative imbalance and biogenic amine catabolism.
Gunasingh MJ; Philip JE; Ashok BS; Kirubagaran R; Jebaraj WC; Davis GD; Vignesh S; Dhandayuthapani S; Jayakumar R
Life Sci; 2008 Jul; 83(3-4):96-102. PubMed ID: 18590917
[TBL] [Abstract][Full Text] [Related]
23. Dynamics of Abeta turnover and deposition in different beta-amyloid precursor protein transgenic mouse models following gamma-secretase inhibition.
Abramowski D; Wiederhold KH; Furrer U; Jaton AL; Neuenschwander A; Runser MJ; Danner S; Reichwald J; Ammaturo D; Staab D; Stoeckli M; Rueeger H; Neumann U; Staufenbiel M
J Pharmacol Exp Ther; 2008 Nov; 327(2):411-24. PubMed ID: 18687920
[TBL] [Abstract][Full Text] [Related]
24. Antioxidative and anti-inflammatory effects of four cysteine-containing agents in striatum of MPTP-treated mice.
Chen CM; Yin MC; Hsu CC; Liu TC
Nutrition; 2007; 23(7-8):589-97. PubMed ID: 17574387
[TBL] [Abstract][Full Text] [Related]
25. 1-(3',4'-Dichloro-2-fluoro[1,1'-biphenyl]-4-yl)-cyclopropanecarboxylic acid (CHF5074), a novel gamma-secretase modulator, reduces brain beta-amyloid pathology in a transgenic mouse model of Alzheimer's disease without causing peripheral toxicity.
Imbimbo BP; Del Giudice E; Colavito D; D'Arrigo A; Dalle Carbonare M; Villetti G; Facchinetti F; Volta R; Pietrini V; Baroc MF; Serneels L; De Strooper B; Leon A
J Pharmacol Exp Ther; 2007 Dec; 323(3):822-30. PubMed ID: 17895400
[TBL] [Abstract][Full Text] [Related]
26. Beta-amyloid (1-42)-induced learning and memory deficits in mice: involvement of oxidative burdens in the hippocampus and cerebral cortex.
Jhoo JH; Kim HC; Nabeshima T; Yamada K; Shin EJ; Jhoo WK; Kim W; Kang KS; Jo SA; Woo JI
Behav Brain Res; 2004 Dec; 155(2):185-96. PubMed ID: 15364477
[TBL] [Abstract][Full Text] [Related]
27. Decrease in brain soluble amyloid precursor protein β (sAPPβ) in Alzheimer's disease cortex.
Wu G; Sankaranarayanan S; Hsieh SH; Simon AJ; Savage MJ
J Neurosci Res; 2011 Jun; 89(6):822-32. PubMed ID: 21433051
[TBL] [Abstract][Full Text] [Related]
28. Behavioral stress accelerates plaque pathogenesis in the brain of Tg2576 mice via generation of metabolic oxidative stress.
Lee KW; Kim JB; Seo JS; Kim TK; Im JY; Baek IS; Kim KS; Lee JK; Han PL
J Neurochem; 2009 Jan; 108(1):165-75. PubMed ID: 19012747
[TBL] [Abstract][Full Text] [Related]
29. Increased plaque burden in brains of APP mutant MnSOD heterozygous knockout mice.
Li F; Calingasan NY; Yu F; Mauck WM; Toidze M; Almeida CG; Takahashi RH; Carlson GA; Flint Beal M; Lin MT; Gouras GK
J Neurochem; 2004 Jun; 89(5):1308-12. PubMed ID: 15147524
[TBL] [Abstract][Full Text] [Related]
30. Immunomodulation of AβPP processing alleviates amyloid-β-related pathology in Alzheimer's disease transgenic mice.
Arbel-Ornath M; Becker M; Rabinovich-Toidman P; Gartner M; Solomon B
J Alzheimers Dis; 2010; 22(2):469-82. PubMed ID: 20847413
[TBL] [Abstract][Full Text] [Related]
31. Potential in vivo amelioration by N-acetyl-L-cysteine of oxidative stress in brain in human double mutant APP/PS-1 knock-in mice: toward therapeutic modulation of mild cognitive impairment.
Huang Q; Aluise CD; Joshi G; Sultana R; St Clair DK; Markesbery WR; Butterfield DA
J Neurosci Res; 2010 Sep; 88(12):2618-29. PubMed ID: 20648652
[TBL] [Abstract][Full Text] [Related]
32. Mutations in amyloid precursor protein and presenilin-1 genes increase the basal oxidative stress in murine neuronal cells and lead to increased sensitivity to oxidative stress mediated by amyloid beta-peptide (1-42), HO and kainic acid: implications for Alzheimer's disease.
Mohmmad Abdul H; Sultana R; Keller JN; St Clair DK; Markesbery WR; Butterfield DA
J Neurochem; 2006 Mar; 96(5):1322-35. PubMed ID: 16478525
[TBL] [Abstract][Full Text] [Related]
33. Fibroblast growth factor 21 protects mouse brain against D-galactose induced aging via suppression of oxidative stress response and advanced glycation end products formation.
Yu Y; Bai F; Wang W; Liu Y; Yuan Q; Qu S; Zhang T; Tian G; Li S; Li D; Ren G
Pharmacol Biochem Behav; 2015 Jun; 133():122-31. PubMed ID: 25871519
[TBL] [Abstract][Full Text] [Related]
34. Astrocytic expression of the Alzheimer's disease beta-secretase (BACE1) is stimulus-dependent.
Hartlage-Rübsamen M; Zeitschel U; Apelt J; Gärtner U; Franke H; Stahl T; Günther A; Schliebs R; Penkowa M; Bigl V; Rossner S
Glia; 2003 Jan; 41(2):169-79. PubMed ID: 12509807
[TBL] [Abstract][Full Text] [Related]
35. Oxidative stress status and RNA expression in hippocampus of an animal model of Alzheimer's disease after chronic exposure to aluminum.
Garcia T; Esparza JL; Nogués MR; Romeu M; Domingo JL; Gómez M
Hippocampus; 2010 Jan; 20(1):218-25. PubMed ID: 19405147
[TBL] [Abstract][Full Text] [Related]
36. Age-dependent differential expression of BACE splice variants in brain regions of tg2576 mice.
Zohar O; Pick CG; Cavallaro S; Chapman J; Katzav A; Milman A; Alkon DL
Neurobiol Aging; 2005; 26(8):1167-75. PubMed ID: 15917100
[TBL] [Abstract][Full Text] [Related]
37. Ergothioneine and melatonin attenuate oxidative stress and protect against learning and memory deficits in C57BL/6J mice treated with D-galactose.
Song TY; Lin HC; Chen CL; Wu JH; Liao JW; Hu ML
Free Radic Res; 2014 Sep; 48(9):1049-60. PubMed ID: 24797165
[TBL] [Abstract][Full Text] [Related]
38. Alleviative effects of s-allyl cysteine and s-ethyl cysteine on MCD diet-induced hepatotoxicity in mice.
Lin CC; Yin MC; Liu WH
Food Chem Toxicol; 2008 Nov; 46(11):3401-6. PubMed ID: 18786595
[TBL] [Abstract][Full Text] [Related]
39. Glycyrrhizic acid attenuated glycative stress in kidney of diabetic mice through enhancing glyoxalase pathway.
Wang ZH; Hsieh CH; Liu WH; Yin MC
Mol Nutr Food Res; 2014 Jul; 58(7):1426-35. PubMed ID: 24585461
[TBL] [Abstract][Full Text] [Related]
40. Effects of C-glycosylation on anti-diabetic, anti-Alzheimer's disease and anti-inflammatory potential of apigenin.
Choi JS; Islam MN; Ali MY; Kim EJ; Kim YM; Jung HA
Food Chem Toxicol; 2014 Feb; 64():27-33. PubMed ID: 24291393
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
